watch
Transgene SA

Transgene SA

Sector: Pharmaceutical Preparations Region: France


: | Euronext Paris: TNG


Transgene SA is engaged in the research and development of therapeutic vaccines and immunotherapy products. Its products include the TG4010 and Pexa-Vec for cancer treatment; and TG4040 and TG4001 for the chronic infectious diseases. The company was founded in December 1979 and is headquartered in Illkirch-Graffenstaden, France.

× We're Sorry! We do not have an investor kit available for this company. Tell us you want one!

News & Analysis